Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Author: Lauren Haase

Vensana in the News

New med-tech investment firm Vensana Capital launches $225 million fund

Vensana in the News

Minneapolis-based Vensana Unveils $225 Million Venture Capital Fund

Vensana in the News

Co-founded by Versant, NEA investors, new medtech VC firm kicks off inaugural fund with $225M bounty

Vensana in the News

New Medtech Investor Vensana Closes $225 Million Debut Fund

Events

Kirk Nielsen featured at MedTech Strategist Medical Alley Innovation Summit 2019

Events

Vensana Capital Co-Organizes 26th Annual Phoenix Conference

Events

TEDCO to Host Entrepreneur Expo on October 29 – Vensana Capital’s Justin Klein and AllegisCyber’s Bob Ackerman morning keynotes at the Expo

TEDCO’s annual Entrepreneur Expo was established to spotlight entrepreneurship in the region by bringing together Maryland’s various resources for a day of celebration.

Events

Justin Klein featured at Virginia Bio Insights at University of Virginia Darden School of Business

Portfolio News

Two medical device makers in Wayne get big boosts

Portfolio News

Wayne medical device developer and its spin-off reel in $62 million

Events

Kirk Nielsen to Co-Chair 2019 Medtech Investing Conference

Portfolio News

Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of Its Duo Venous Stent System™

Portfolio News

Intact Vascular Announces $25 Million Financing with Vensana Capital to Drive Commercialization of the Tack Endovascular System®

Events

Justin Klein featured at Pittsburgh Life Sciences Week 2019

19

Novel FDA PMA & de novo 510k approvals

45

U.S. Commercial Product Launches

34

Level I Clinical Trials

26

Strategic Financings

28

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS®

Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

Get in Touch

Our Latest

See All News
Alleviant Medical Closes $75M in Financing; Receives FDA IDE Approval for Pivotal Clinical Trial
Curate Biosciences launches its first product to transform cell therapy manufacturing costs and performance
Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation
Resources
News LP Access
Contact
[email protected] 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 101 Church Street Suite D Vienna, VA 22180

© 2022 Vensana Capital Management, LLC | Privacy | Terms & Conditions